BSH 2024 Registration | British Society for Haematology ASM
Registration for BSH 2024 is now open! Our ASM takes place from 28-30 April 2024 in The ACC, Liverpool. Don’t miss out on our Early Bird fees!
Registration for BSH 2024 is now open! Our ASM takes place from 28-30 April 2024 in The ACC, Liverpool. Don’t miss out on our Early Bird fees!
PHILADELPHIA (April 29, 2024) —Following her double mastectomy in October of 2019, Agnes Judge fell into a deep depression – experiencing what she recalls as…
Manmeet Singh Ahluwalia, MD, MBA, FASCO, discusses how advancements in precision medicine have improved outcomes for patients with brain metastases.
Dr. Bose discusses his perspective on quality-of-life preservation for his patients with myelofibrosis, including the symptoms that have the most negative impact on patients’ quality…
Hypofractionated IMRT with concurrent chemotherapy appears to be well tolerated as post-operative treatment in patients with cervical cancer.
In this issue of Blood, Leung et al1 present preclinical findings demonstrating the potential of neoantigen-specific T cells to recognize acute myeloid leu
Using a cohort from the Pathways Study, researchers sought to determine the influence of healthy eating habits on risk of heart disease among women treated…
The FDA has granted breakthrough therapy designation to ziftomenib for the treatment of NPM1-mutant acute myeloid leukemia.
Journal of Neuro-Oncology – Diffuse midline gliomas (DMG) include all midline gliomas with a point mutation to the histone H3 gene resulting in the substitution…
The 15 inductees have been selected by their peers for their remarkable achievements in oncology research and clinical practice.
In acute myeloid leukemia, investigators are exploring novel agents engineered to target adhesion factors, which can mobilize persistent leukemic stem cells from the bone marrow…